GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Samsung Pharmaceutical Co Ltd (XKRX:001360) » Definitions » E10

Samsung Pharmaceutical Co (XKRX:001360) E10 : ₩0.00 (As of Dec. 2024)


View and export this data going back to 1975. Start your Free Trial

What is Samsung Pharmaceutical Co E10?

E10 is a concept invented by Prof. Robert Shiller, who uses E10 for his Shiller P/E calculation. E10 is the average of the inflation adjusted earnings of a company over the past 10 years.

Samsung Pharmaceutical Co's adjusted earnings per share data for the three months ended in Dec. 2024 was ₩-192.000. Add all the adjusted EPS for the past 10 years together and divide 10 will get our e10, which is ₩0.00 for the trailing ten years ended in Dec. 2024.

Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the E10 growth rate using E10 data.

During the past 13 years, the highest 3-Year average E10 Growth Rate of Samsung Pharmaceutical Co was 2.10% per year. The lowest was -10.60% per year. And the median was -6.70% per year.

As of today (2025-04-06), Samsung Pharmaceutical Co's current stock price is ₩1467.00. Samsung Pharmaceutical Co's E10 for the quarter that ended in Dec. 2024 was ₩0.00. Samsung Pharmaceutical Co's Shiller PE Ratio of today is .


Samsung Pharmaceutical Co E10 Historical Data

The historical data trend for Samsung Pharmaceutical Co's E10 can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Samsung Pharmaceutical Co E10 Chart

Samsung Pharmaceutical Co Annual Data
Trend Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23 Dec24
E10
Get a 7-Day Free Trial Premium Member Only Premium Member Only -422.70 -473.80 -502.47 -396.41 -

Samsung Pharmaceutical Co Quarterly Data
Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24
E10 Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only -396.41 -396.70 - - -

Competitive Comparison of Samsung Pharmaceutical Co's E10

For the Drug Manufacturers - Specialty & Generic subindustry, Samsung Pharmaceutical Co's Shiller PE Ratio, along with its competitors' market caps and Shiller PE Ratio data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Samsung Pharmaceutical Co's Shiller PE Ratio Distribution in the Drug Manufacturers Industry

For the Drug Manufacturers industry and Healthcare sector, Samsung Pharmaceutical Co's Shiller PE Ratio distribution charts can be found below:

* The bar in red indicates where Samsung Pharmaceutical Co's Shiller PE Ratio falls into.


;
;

Samsung Pharmaceutical Co E10 Calculation

E10 is a concept invented by Prof. Robert Shiller, who uses E10 for his Shiller P/E calculation. When we calculate the today's Shiller P/E ratio of a stock, we use today's price divided by E10.

What is E10? How do we calculate E10?

E10 is the average of the inflation adjusted earnings of a company over the past 10 years. Let's use an example to explain.

If we want to calculate the E10 of Wal-Mart (WMT) for Dec. 31, 2010, we need to have the inflation data and the earnings from 2001 through 2010.

We adjusted the earnings of 2001 earnings data with the total inflation from 2001 through 2010 to the equivalent earnings in 2010. If the total inflation from 2001 to 2010 is 40%, and Wal-Mart earned $1 a share in 2001, then the 2001's equivalent earnings in 2010 is $1.4 a share. If Wal-Mart earns $1 again in 2002, and the total inflation from 2002 through 2010 is 35%, then the equivalent 2002 earnings in 2010 is $1.35. So on and so forth, you get the equivalent earnings of past 10 years. Then you add them together and divided the sum by 10 to get E10.

Please note that we use the CPI data of the country/region where the company is headquartered. If the CPI data for that country/region is not available, then we will use the CPI data of the United States as default.

For example, Samsung Pharmaceutical Co's adjusted earnings per share data for the three months ended in Dec. 2024 was:

Adj_EPS= Earnings per Share (Diluted) /CPI of Dec. 2024 (Change)*Current CPI (Dec. 2024)
=-192/121.1352*121.1352
=-192.000

Current CPI (Dec. 2024) = 121.1352.

Samsung Pharmaceutical Co Quarterly Data

per share eps CPI Adj_EPS
201503 6.930 99.721 8.418
201506 154.775 100.051 187.392
201509 -129.364 100.111 -156.532
201512 -57.752 100.220 -69.804
201603 -64.682 100.561 -77.916
201606 -90.863 100.791 -109.204
201609 -111.413 101.461 -133.017
201612 -265.740 101.561 -316.956
201703 -50.342 102.851 -59.292
201706 -39.613 102.611 -46.764
201709 -52.873 103.491 -61.888
201712 -14.030 102.991 -16.502
201803 0.264 104.101 0.307
201806 42.405 104.130 49.330
201809 14.436 105.651 16.552
201812 -87.517 104.351 -101.594
201903 80.299 104.491 93.090
201906 -2.707 104.881 -3.127
201909 -97.442 105.200 -112.202
201912 123.607 105.121 142.437
202003 -190.372 105.354 -218.888
202006 -109.171 105.112 -125.813
202009 16.240 106.198 18.524
202012 -307.663 105.765 -352.373
202103 -196.688 107.357 -221.931
202106 -84.810 107.579 -95.497
202109 -90.224 108.759 -100.491
202112 -179.546 109.676 -198.305
202203 -19.849 111.848 -21.497
202206 -116.389 114.072 -123.595
202209 -51.428 114.715 -54.306
202212 -149.772 115.179 -157.517
202303 -37.894 116.507 -39.399
202306 -48.721 117.182 -50.365
202309 -83.908 118.964 -85.440
202312 -164.207 118.837 -167.382
202403 -61.000 120.123 -61.514
202406 -109.000 120.007 -110.024
202409 195.000 120.861 195.442
202412 -192.000 121.135 -192.000

Add all the adjusted EPS together and divide 10 will get our e10.


Samsung Pharmaceutical Co  (XKRX:001360) E10 Explanation

If a company grows much fast than inflation, E10 may underestimate the company's earnings power. Shiller PE Ratio can seem to be too high even the actual P/E is low.

For the Shiller P/E, the earnings of the past 10 years are inflation-adjusted and averaged. The result is used for P/E calculation. Since it looks at the average over the last 10 years, the Shiller P/E is also called PE10.

The Shiller P/E was first used by professor Robert Shiller to measure the valuation of the overall market. The same calculation is applied here to individual companies.


Be Aware

Shiller PE Ratio works better for cyclical companies. It gives you a better idea on the company's real earnings power.


Samsung Pharmaceutical Co E10 Related Terms

Thank you for viewing the detailed overview of Samsung Pharmaceutical Co's E10 provided by GuruFocus.com. Please click on the following links to see related term pages.


Samsung Pharmaceutical Co Business Description

Traded in Other Exchanges
N/A
Address
35 Jeyakgongdan 2-gil, Hyangnam-eup, Hwaseong, KOR, 445-746
Samsung Pharmaceutical Co Ltd is a South Korea based company engages in the manufacturing, supply, and distribution of pharmaceutical products. The company offers over the counter (OTC) drugs, prescription drugs, energy drinks, insecticides, and healthcare food items.

Samsung Pharmaceutical Co Headlines

No Headlines